Nicotinamide riboside kinase structures reveal new pathways to NAD+.
The eukaryotic nicotinamide riboside kinase (Nrk) pathway, which is induced in response to nerve damage and promotes replicative life span in yeast, converts nicotinamide riboside to nicotinamide adenine dinucleotide (NAD+) by phosphorylation and adenylylation. Crystal structures of human Nrk1 bound...
Guardado en:
Autores principales: | Wolfram Tempel, Wael M Rabeh, Katrina L Bogan, Peter Belenky, Marzena Wojcik, Heather F Seidle, Lyudmila Nedyalkova, Tianle Yang, Anthony A Sauve, Hee-Won Park, Charles Brenner |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2007
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6e381eb8f8a6473f955a9c049c6e9369 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
NAD+ augmentation with nicotinamide riboside improves lymphoid potential of Atm −/− and old mice HSCs
por: Le Zong, et al.
Publicado: (2021) -
Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults
por: Christopher R. Martens, et al.
Publicado: (2018) -
NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells
por: Joanna Ratajczak, et al.
Publicado: (2016) -
Nicotinamide riboside is uniquely and orally bioavailable in mice and humans
por: Samuel A. J. Trammell, et al.
Publicado: (2016) -
Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD+ levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study
por: Ryan W. Dellinger, et al.
Publicado: (2017)